SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Hope for new psoriasis treatment
Fri October 30th - A possible new therapy for psoriasis has shown promise, a European conference has heard. More
Shop workers' risk of getting COVID-19
Fri October 30th - Customer-facing shop staff are about five times more likely to test positive for COVID-19 than their colleagues in other positions, a small American study has found. More
CA125 test better at predicting ovarian cancer
Fri October 30th - A readily available blood test is able to predict ovarian cancer risk more successfully than previously thought – particularly for the over 50s, according to newly published findings. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Embrace medicinal cannabis, say experts

Tuesday September 22nd 2020

Attitudes towards medicinal cannabis use must change among the medical and pharmaceutical sector in the UK, according to an analysis published today.

Although cannabis-based products for medicinal use (CBPMs) were made legal in November 2018, almost no NHS prescriptions have been issued and fewer than 100 have been made available from private providers, costing at least £1,000 a month.

Writing in BMJ Open, the researchers from Imperial College London and the London School of Economics and Drug Science said it has meant hundreds of thousands of UK patients were self-medicating with illegal cannabis-based products, while some parents of children with severe epilepsy continued to source cannabinoid medication from overseas.

The research team consulted with parents and patients, prescribers, pharmacists and decision makers and found distinct barriers to prescribing that still need to be overcome to improve patient access to medical cannabis in the UK, including a perceived lack of scientific evidence.

They add that part of the resistance to prescribing medicinal cannabis could be because it was being driven by patients and not doctors, which the latter group might resent, while the government also states that medical cannabis is a “special’ product, which has led to challenges for prescribers.

Prescribing medicinal cannabis could also result in cost savings to the NHS because of reduced hospital stays and less prescribing of other medicines, particularly opioids, for chronic pain, they argued.

“The failure of the medical and pharmacy professions to embrace CBPMs despite their being made ‘legal’ over 18 months ago is a great worry to patients,” they write.

Nutt D, Bazire S, Phillips LD et al. So near yet so far: why won’t the UK prescribe medical cannabis? BMJ Open 22 September 2020; doi:10.1136/bmjopen-2020-038687

https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2020-038687

Tags: Alternative Therapy | Pain Relief | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES